Global Cancer Statistics, 2002

Global Cancer Statistics, 2002

March/April 2005 | D. Max Parkin, MD; Freddie Bray; J. Ferlay; Paola Pisani, PhD
Global Cancer Statistics, 2002: Estimates of the worldwide incidence, mortality, and prevalence of 26 cancers in 2002 are presented in the GLOBOCAN series. Overall, there were 10.9 million new cancer cases, 6.7 million deaths, and 24.6 million people alive with cancer (within three years of diagnosis). The most commonly diagnosed cancers are lung (1.35 million), breast (1.15 million), and colorectal (1 million). The most common causes of cancer death are lung cancer (1.18 million), stomach cancer (700,000), and liver cancer (598,000). Breast cancer is the most prevalent cancer, with 4.4 million survivors up to five years after diagnosis. There are significant variations in cancer risk by geographic area, largely due to lifestyle and environmental risk factors. The study provides global estimates of cancer incidence, mortality, and prevalence for 26 cancer types, with data from 20 world areas. The estimates are based on data from cancer registries, mortality records, and survival data. The study highlights the importance of cancer prevention and early detection, as well as the impact of lifestyle and environmental factors on cancer risk. The results show that cancer is not a rare disease in most developing countries, with similar mortality rates in developed and developing countries. The study also notes that cancer survival rates vary significantly between regions, with better survival in developed countries. The study provides detailed data on the incidence, mortality, and prevalence of various cancers, including lung, breast, colon and rectum, stomach, liver, prostate, and cervical cancers. The study also discusses the impact of lifestyle factors such as smoking, diet, and alcohol consumption on cancer risk. The study concludes that cancer is a major global health issue, with significant variations in risk and outcomes between regions and populations. The study emphasizes the importance of cancer prevention, early detection, and improved treatment to reduce the global burden of cancer.Global Cancer Statistics, 2002: Estimates of the worldwide incidence, mortality, and prevalence of 26 cancers in 2002 are presented in the GLOBOCAN series. Overall, there were 10.9 million new cancer cases, 6.7 million deaths, and 24.6 million people alive with cancer (within three years of diagnosis). The most commonly diagnosed cancers are lung (1.35 million), breast (1.15 million), and colorectal (1 million). The most common causes of cancer death are lung cancer (1.18 million), stomach cancer (700,000), and liver cancer (598,000). Breast cancer is the most prevalent cancer, with 4.4 million survivors up to five years after diagnosis. There are significant variations in cancer risk by geographic area, largely due to lifestyle and environmental risk factors. The study provides global estimates of cancer incidence, mortality, and prevalence for 26 cancer types, with data from 20 world areas. The estimates are based on data from cancer registries, mortality records, and survival data. The study highlights the importance of cancer prevention and early detection, as well as the impact of lifestyle and environmental factors on cancer risk. The results show that cancer is not a rare disease in most developing countries, with similar mortality rates in developed and developing countries. The study also notes that cancer survival rates vary significantly between regions, with better survival in developed countries. The study provides detailed data on the incidence, mortality, and prevalence of various cancers, including lung, breast, colon and rectum, stomach, liver, prostate, and cervical cancers. The study also discusses the impact of lifestyle factors such as smoking, diet, and alcohol consumption on cancer risk. The study concludes that cancer is a major global health issue, with significant variations in risk and outcomes between regions and populations. The study emphasizes the importance of cancer prevention, early detection, and improved treatment to reduce the global burden of cancer.
Reach us at info@study.space